Excerpt
If you were going to live to be 100, would you want to know it?
When it becomes affordable to have one’s genome sequenced, perhaps in a few years, a longevity test, though not a foolproof one, may be feasible, if a new claim holds up. Scientists studying the genomes of centenarians in New England say they have identified a set of genetic variants that predicts extreme longevity with 77 percent accuracy.
The centenarians had just as many disease-associated variants as shorter-lived mortals, so their special inheritance must be genes that protect against disease, said the authors of the study, a team led by Paola Sebastiani and Thomas T. Perls of Boston University. Their report appears in Thursday’s issue of Science.
The finding, if confirmed, would complicate proposals for predicting someone’s liability to disease based on disease-causing variants in the person’s genome, since much would depend on whether or not an individual possessed protective genes as well.
“I think it’s a quite striking finding,” said Nir Barzilai, an expert on longevity at the Albert Einstein College of Medicine. It shows that only a limited number of favorable genes are required to attain great age, he said. Identifying these genes would provide protection against all the diseases of old age, a more powerful strategy than tackling each disease one by one.
“I feel there’s an elephant in the room and no one realizes it’s really important — this is the next step to make us all healthy,” Dr. Barzilai said.
Like many things humans do, this is a double-edged sword.
Lets individuals know their chances of longevity, but can be abused by the healthcare AND insurance industry to boost profits.
No comments:
Post a Comment